Purified CD34(+) cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial

BACKGROUND: Peripheral blood mononuclear cells (PBMNCs) and purified CD34(+) cells (PCCs) are increasingly being used at treating no-option critical limb ischaemia (NO-CLI). We aimed to compare the efficacies and uncover the advantages associated with each treatment approach. METHODS: A randomised s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Zhihui, Pan, Tianyue, Fang, Yuan, Wei, Zheng, Gu, Shiyang, Fang, Gang, Liu, Yifan, Luo, Yang, Liu, Hao, Zhang, Tiejun, Hu, Meiyu, Guo, Daqiao, Xu, Xin, Chen, Bin, Jiang, Junhao, Yang, Jue, Shi, Zhenyu, Zhu, Ting, Shi, Yun, Liu, Peng, Fu, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156701/
https://www.ncbi.nlm.nih.gov/pubmed/30172703
http://dx.doi.org/10.1016/j.ebiom.2018.08.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156701/
https://www.ncbi.nlm.nih.gov/pubmed/30172703
http://dx.doi.org/10.1016/j.ebiom.2018.08.038

Ejemplares similares